ITEM METADATA RECORD
Title: An efficient synthesis and antiviral activity evaluation of 1-[4-(5-phenyl-4, 5 dihydro-1H-pyrazole [& (4, 5 dihydroisoxazole)]-3-yl)-phenyl]-pyrrole-2, 5-dione derivates
Authors: Patel, J ×
Malani, M
Andrei, Graciela
Balzarini, Jan
Snoeck, Robert
Dholakiya, B #
Issue Date: Jan-2014
Publisher: Bentham Science Publishers
Series Title: Anti-Infective Agents in Medicinal Chemistry vol:12 pages:104-111
Abstract: Preparation of new series of 1-[4-(5-Phenyl-4,5 dihydro-1H-pyrazole-3-yl)- phenyl]-pyrrole-2,5-dione and 1-[4-(5-Phenyl-4,5 dihydroisooxazole-3-yl)- phenyl]-pyrrole-2,5-dione derivatives, derived from alpha,beta-unsaturated ketones with objective of obtaining lead compounds for future development as antiviral agents. The inhibition of virus-induced cytopathicity or plaque formation in HEL [herpes simplex virus type 1 (HSV-1) (KOS), HSV-2 (G), vaccinia virus, vesicular stomatitis virus, cytomegalovirus (HCMV), and varicella-zoster virus (VZV)], Vero (parainfluenza-3, reovirus-1, Sindbis virus and Coxsackie B4), HeLa (vesicular stomatitis virus, Coxsackie virus B4, and respiratory syncytial virus) or MDCK [influenza A (H1N1; H3N2) and influenza B] cell cultures by synthesized derivatives. All the compounds were characterized by physical, spectroscopic and elemental analysis. Among the fourteen synthesized targets only compounds 3g and 4e showed activity against RSV (EC50 = 37 mu M and 46 mu M with affecting cell morphology at concentrations of, respectively, 254 mu M and 286 mu M) Compound 3g also showed weak activity against feline corona virus (EC50 value of 29 mu M and a MCC of 107 mu M) for CRFK cells. Feline corona virus was also weakly inhibited by compound 3f (EC50=39 mu M) that altered cell morphology at a concentration of 231 mu M. Except for feline corona virus, none of the other viruses was inhibited by compound 3f. Low selectivity indices (SIs), defined as ratio MCC/EC50, were observed SI=4 and SI=6 for compounds 3g and 3f against feline corona virus respectively, while SI=6 for compound 4e against RSV, and SI=7 for compound 3g against RSV. Biological evaluation was performed using acyclovir, brivudin, gancilcovir, cidofovir against herpes and poxviruses while ribavirin against RNA viruses, reference standard drugs.
ISSN: 1568-0126
Publication status: published
KU Leuven publication type: DI
Appears in Collections:Laboratory of Virology and Chemotherapy (Rega Institute)
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
2014027.pdf Published 143KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members

 




All items in Lirias are protected by copyright, with all rights reserved.